Hydrogen Water and Eye Health: What Recent Research Suggests

The retina is one of the most metabolically active tissues in the human body. Gram for gram, it burns through oxygen at a rate that rivals almost anything else you carry around — and that appetite comes with a cost. High oxygen turnover means a steady stream of reactive oxygen species, the unstable molecules that researchers have spent decades linking to tissue damage. The eye sits in constant light, runs hot metabolically, and has limited room to repair itself. So when a small antioxidant molecule started showing up in ophthalmology journals, vision researchers paid attention.

That molecule is hydrogen — molecular hydrogen, H₂, the same gas dissolved into hydrogen water. The eye-specific research is younger and smaller than the work on inflammation or metabolic markers, and most of it still lives in animal models. But it is real, peer-reviewed, and as of 2026 growing. This article walks through what it reports, where the human evidence stands, and what it does not yet show.

The eye is built for light, and that makes it a target for oxidative stress

To understand why hydrogen ended up in vision research at all, it helps to understand why the eye is so exposed in the first place.

The most metabolically active tissue you own

Photoreceptors — the rods and cones that turn light into signals — are extraordinarily busy cells. They consume large amounts of oxygen, they are packed with mitochondria, and they sit in light for most of your waking hours. Every one of those features generates reactive oxygen species. In moderation, normal; in excess, researchers have long associated them with damage to the delicate structures of the retina and the lens.

The eye has its own antioxidant defenses, but they can be overwhelmed — by aging, by high blood sugar, by intense light, by injury. That gap between the oxidative load and the body's ability to neutralize it is what researchers call oxidative stress. It is exactly the gap molecular hydrogen has been studied to address.

Where oxidative damage tends to show up

Much of the ophthalmology literature on oxidative stress clusters around a handful of conditions: the retina in diabetes, the light-exposed retina, the vessels that feed the back of the eye, the ocular surface in dry eye, and the lens in cataract formation. Different problems, one common thread — and that shared question of whether reducing oxidative load changes the picture is why a single small molecule keeps reappearing across otherwise unrelated eye studies.

What molecular hydrogen is, and why eye researchers took notice

Molecular hydrogen is the lightest, smallest molecule there is. It is colorless, tasteless, and — at the concentrations used in research — well tolerated. What makes it interesting to scientists is not that it is a powerful antioxidant. It is that it appears to be a selective one.

A selective antioxidant, not a sledgehammer

The foundational paper here is Ohsawa and colleagues, published in Nature Medicine in 2007. According to PubMed, the researchers reported that hydrogen appeared to selectively reduce the hydroxyl radical — described in the study as the most cytotoxic of the reactive oxygen species — while leaving other ROS that play useful signaling roles largely untouched (DOI). That selectivity is the whole reason the field exists. A blunt antioxidant mops up everything, including molecules the body uses on purpose; hydrogen, the researchers proposed, was more discriminating.

For the eye, that distinction matters. Vision depends on tightly regulated signaling, and a treatment that flattened all reactive oxygen species indiscriminately could blunt processes the retina needs. That is part of why ophthalmology researchers were willing to test hydrogen at all. The same selectivity logic later drew researchers to another sensory organ — see the auditory research.

Small enough to reach hard-to-reach tissue

The other reason is physical. Hydrogen is so small that it diffuses readily across cell membranes and into tissue that many larger compounds struggle to reach. In the eye, where barriers make drug delivery genuinely difficult, a molecule that moves freely is attractive to study. None of this claims hydrogen does anything for your vision — it is the reason researchers thought it worth finding out.

The ways hydrogen reaches the eye in research

Drinking it, inhaling it, and applying it

One honest complication runs through the eye literature: the studies use hydrogen in several different forms. Some give animals hydrogen-rich water to drink. Some use hydrogen-rich saline. Many use hydrogen gas, inhaled. These are not interchangeable, and a finding from inhaled gas does not automatically transfer to a glass of hydrogen water. We will flag the delivery method as we go — it is one of the most important caveats in reading this research fairly, because drinking water is the form most people use at home and the one with the least eye-specific evidence so far.

What the retinal research suggests

The retina is where most of the eye work has happened. Four studies give a representative picture.

Retinal ischemia and reperfusion

When blood flow to the retina is cut off and then restored, a burst of oxidative damage follows — a process called ischemia–reperfusion injury. Otsuka and colleagues, writing in Graefe's Archive for Clinical and Experimental Ophthalmology in 2023, created this injury in rats and added low-concentration hydrogen gas (1.8%) to the air the animals breathed. According to PubMed, the hydrogen-exposed group showed a thicker inner retinal layer, better preserved electrical responses on electroretinography, and lower levels of inflammatory markers such as interleukin-6 and tumor necrosis factor alpha than untreated animals (DOI). Inhaled hydrogen gas in rats — not drinking water, and not people.

Diabetic changes in retinal blood flow

Here the delivery method is closer to home. Sugiyama and colleagues, in Translational Vision Science & Technology in 2024, gave type 2 diabetic mice hydrogen-rich water to drink. According to PubMed, the researchers reported that the animals drinking hydrogen water showed improved regulation of retinal blood flow, lower blood glucose, reduced markers of glial activation, and suppression of an oxidative stress marker called 3-nitrotyrosine compared with controls (DOI). A co-author on that paper is Ikuroh Ohsawa — the same researcher behind the 2007 selective-antioxidant work. A small, connected field.

Light-induced retinal damage

Excessive blue light can injure the retina. Wang and colleagues, in Photochemistry and Photobiology in 2024, exposed rats to blue light and then treated them with hydrogen-rich saline. According to PubMed, the researchers reported that the hydrogen-treated animals recovered the function and protein expression of certain light-sensing retinal ganglion cells faster than untreated animals did (DOI).

The retina under simulated weightlessness

One of the stranger entries comes from space medicine, where long spaceflight is associated with changes to eye structure that some researchers link to oxidative stress. Mu and colleagues, in Life Sciences in Space Research in 2025, simulated weightlessness in rats and gave some of them hydrogen-rich water. According to PubMed, the researchers reported that hydrogen-rich water reduced the retinal degeneration, improved retinal function, and lowered oxidative stress markers in the simulated-microgravity animals, acting through a pathway involving Nrf2 (DOI).

Blood-vessel overgrowth and the retinopathy-of-prematurity work

Abnormal new blood vessel growth in the retina drives several serious eye conditions, including retinopathy of prematurity, a leading cause of childhood blindness. Guo and colleagues, in Biological Research in 2024, studied molecular hydrogen in a mouse model of oxygen-induced retinopathy. According to PubMed, the researchers reported that hydrogen did not disturb normal blood-vessel development but reduced the abnormal neovascularization and protected supporting retinal cells, apparently via the Nrf2 pathway and the Dll4–Notch axis (DOI). Preclinical — and framed by the authors as a candidate worth further study, not a finished answer.

The honest part: where hydrogen did not move the needle

Not every eye study has been positive, and the honest broker's job is to say so. Yan and colleagues, in Frontiers in Pharmacology in 2024, tested molecular hydrogen — both as gas and as hydrogen-rich saline — in a mouse model of inherited retinitis pigmentosa, a genetic form of retinal degeneration. According to PubMed, the researchers reported no significant difference between the hydrogen-treated animals and controls on electroretinography, retinal layer thickness, or the markers they measured (DOI). Their interpretation was that the specific mechanism driving this inherited disease may simply not be one that hydrogen addresses.

That null result is useful. It is a sign the field is testing hydrogen rigorously across different conditions rather than only publishing wins — and it sharpens what the positive studies are actually saying. The pattern that emerges is that hydrogen has shown signals mainly where oxidative stress is a central driver, and little where the underlying problem is something else.

The first human signals

Almost everything above is animal work. The human eye literature is thin — but it is not empty.

What a small clinical study reported

Chen and colleagues, writing in Heliyon in 2023, ran a small clinical study in 13 patients with primary retinitis pigmentosa, who drank hydrogen-rich water twice daily for four weeks. According to PubMed, the researchers reported a statistically significant improvement in best-corrected visual acuity and in several electroretinography measures after the hydrogen-water period, while retinal and choroidal thickness did not change (DOI). The authors described the visual-function change as slight. Thirteen people, four weeks, no placebo arm. A first signal, not a verdict.

The 2026 study that brought eyes back into focus

The most recent entry is what put this topic back on the radar for 2026.

Allergic conjunctivitis in a model

Sakata and colleagues, in the Journal of Ocular Pharmacology and Therapeutics in 2026, looked at the surface of the eye rather than the retina — specifically, allergic conjunctivitis, the itchy, inflamed eyes that millions of people experience seasonally. According to PubMed, the researchers sensitized mice to an allergen and then exposed some of them to hydrogen gas after the allergic challenge. The hydrogen-exposed group showed less eye-scratching behavior and fewer eosinophils (a type of allergy-related immune cell) in their tears than the untreated group (DOI), which the researchers attributed to hydrogen clearing reactive oxygen species involved in itching. Mice, inhaled gas, an allergy model — but a fresh, peer-reviewed addition to a growing list.

The ocular surface: dry eye, cornea, and cataract directions

The retina is not the only place researchers have looked. A 2023 review by Li and colleagues in Pharmaceuticals surveyed the broader picture — and it is the single best map of where this field stands.

Dry eye and the surface of the eye

According to PubMed, the Li review reported that molecular hydrogen has been studied across multiple ophthalmic conditions, including cataract, dry eye disease, and diabetic retinopathy, and noted that hydrogen had been tested in clinical practice for dry eye disease and corneal endothelial injury (DOI). The authors were measured — describing hydrogen as a promising area while emphasizing that larger studies are needed to settle the optimal delivery method and dose. That is a fair summary of the entire eye literature: real signals, genuine interest, early days.

What the safety record looks like

One of the strongest parts of the hydrogen evidence base is its safety profile. Molecular hydrogen has GRAS (Generally Recognized As Safe) status with the FDA for use in food at certain levels, and across a large body of human trials — reviewed by Johnsen and colleagues in 2023 — no significant adverse effects have been reported at the concentrations studied. If you want the fuller picture, our overview of hydrogen water side effects walks through what the safety data shows. As always, anyone with an existing eye condition or other medical concern should talk to their own clinician before changing anything.

Frequently asked questions

Can hydrogen water improve your eyesight?

No study supports that claim, and we are not going to make it. What the research shows is narrower: in animal models, and in one small human study, hydrogen has been associated with changes in markers of retinal oxidative stress and, in a few cases, measures of visual function. Most of it is preclinical. No hydrogen product has been shown to do anything specific for human eyesight. The science is promising and early — both things are true at once.

Is drinking hydrogen water the same as the studies that used inhalation or saline?

Not exactly — and this is the caveat to hold onto. Many eye studies used inhaled hydrogen gas or hydrogen-rich saline rather than drinking water. A few — the diabetic retinal blood flow study, the small human retinitis pigmentosa study — did use water that animals or people drank. But the delivery method varies, and a finding from one form does not automatically carry to another.

How soon will there be solid human eye evidence?

Hard to say. The human work so far is limited to small, early studies, and the reviews in this field consistently call for larger trials to settle dosing and delivery. The trajectory is upward — the 2026 conjunctivitis study is the newest of a steady stream — but the field has not yet produced the large, controlled human eye trials that would turn promise into something firmer. For now: an active, growing area worth watching.

Further Reading

For the broader literature, you can browse PubMed's results for molecular hydrogen and the eye and read the primary sources yourself.

• Li and colleagues (2023), a review in Pharmaceuticals, is the best single overview of where hydrogen-and-the-eye research stands — it walks through cataract, dry eye, and diabetic retinopathy and is candid that larger studies are still needed. PMC10674431.
• Johnsen and colleagues (2023) published a wide review of molecular hydrogen across human clinical trials in Molecules; it is a useful big-picture read on the safety record and the breadth of indications under study. PMID: 38067515.
• The Ohsawa 2007 Nature Medicine paper is the origin point — the study that first proposed hydrogen as a selective antioxidant, and the reference nearly every later eye study cites. PMID: 17486089.
• Sugiyama and colleagues (2024) is the most relevant drinking-water study for the eye: diabetic mice given hydrogen-rich water showed steadier retinal blood flow. A good look at oral delivery specifically. PMC11512563.
• Guo and colleagues (2024) describes how hydrogen affected abnormal retinal blood-vessel growth in a model of retinopathy of prematurity — interesting for anyone curious about the neovascular side of eye disease. PMC11194953.
• Chen and colleagues (2023) reported the small human study in retinitis pigmentosa patients who drank hydrogen-rich water; worth reading for an honest sense of how preliminary the human eye evidence is. PMID: 37860576.
• Yan and colleagues (2024) is the null result — hydrogen showed no benefit in an inherited retinitis pigmentosa model — and is a good example of the field testing its limits rather than only its wins. PMC11025393.

References

1. Ohsawa I, et al. (2007). Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. PMID: 17486089. DOI: 10.1038/nm1577.
2. Otsuka M, et al. (2023). Inhibition of retinal ischemia-reperfusion injury in rats by inhalation of low-concentration hydrogen gas. Graefe's Archive for Clinical and Experimental Ophthalmology. PMID: 37851131. DOI: 10.1007/s00417-023-06262-3.
3. Sugiyama R, et al. (2024). Oral Intake of Hydrogen Water Improves Retinal Blood Flow Dysregulation in Response to Flicker Stimulation and Systemic Hyperoxia in Diabetic Mice. Translational Vision Science & Technology. PMID: 39446362. DOI: 10.1167/tvst.13.10.36.
4. Wang X, et al. (2024). Effect of hydrogen-rich saline on melanopsin after acute blue light-induced retinal damage in rats. Photochemistry and Photobiology. PMID: 38634423. DOI: 10.1111/php.13952.
5. Guo Y, et al. (2024). Molecular hydrogen promotes retinal vascular regeneration and attenuates neovascularization and neuroglial dysfunction in oxygen-induced retinopathy mice. Biological Research. PMID: 38915069. DOI: 10.1186/s40659-024-00515-z.
6. Mu Y, et al. (2025). The effect of Hydrogen-rich water on retinal degeneration in the outer nuclear layer of simulated weightlessness rats. Life Sciences in Space Research. PMID: 40280637. DOI: 10.1016/j.lssr.2025.03.004.
7. Yan W, et al. (2024). Effect of molecular hydrogen on the retinal degeneration of hereditary retinitis pigmentosa: an in vivo study. Frontiers in Pharmacology. PMID: 38638334. DOI: 10.3389/fphar.2023.1294315.
8. Chen X, et al. (2023). The clinical research on the effect of hydrogen-rich water on primary retinitis pigmentosa. Heliyon. PMID: 37860576. DOI: 10.1016/j.heliyon.2023.e20671.
9. Sakata H, et al. (2026). Effects of Inhalation of Hydrogen Gas on Allergic Conjunctivitis Model Mice. Journal of Ocular Pharmacology and Therapeutics. PMID: 42101321. DOI: 10.1177/10807683261415800.
10. Li SY, et al. (2023). Novel Role of Molecular Hydrogen: The End of Ophthalmic Diseases? Pharmaceuticals (Basel). PMID: 38004433. DOI: 10.3390/ph16111567.
11. Johnsen HM, et al. (2023). Molecular Hydrogen Therapy—A Review on Clinical Studies and Outcomes. Molecules. PMID: 38067515. DOI: 10.3390/molecules28237785.

If this is your entry point into hydrogen research, our explainer on what hydrogen water actually is covers the chemistry, and our roundup of what the 2,000+ published studies say gives the wide-angle view. Because the eye work centers on oxidative stress and neural tissue, two companion pieces are especially relevant: hydrogen water and inflammation and the cognitive and brain research — since the retina is, in developmental terms, an outpost of the brain.

This article reports published research for general education. It is not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. All information on this site is provided for educational and general wellness purposes only and should not be considered medical advice. Always consult a qualified healthcare provider before beginning any new wellness practice, especially if you have a medical condition, are pregnant or nursing, or take prescription medications.